The mechanism of increased platelet activity of PCSK9 is not yet fully understood, and more trials can be conducted to further understand the mechanism in order to improve PCSK9 inhibitors and make them more targeted in the treatment of ischemic stroke. The gene discussed is PCSK9; the disease is ischemic stroke.